Potential role of proteasome on c-jun related signaling in hypercholesterolemia induced atherosclerosis

Redox Biology

Volumn 2, Issue 1, 2014, Pages 732-738

  Sozen, Erdi ^a   Karademir, Betul ^a   Yazgan, Burak ^a   Bozaykut, Perinur ^a   Ozer, Nesrin Kartal ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

AP 1; Atherosclerosis; Hypercholesterolemia; JNK1; Proteasome; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CD36 ANTIGEN; CHOLESTEROL; GELATINASE B; JANUS KINASE 1; MALONALDEHYDE; MESSENGER RNA; PROTEASOME; PROTEIN C JUN; MITOGEN ACTIVATED PROTEIN KINASE 9; PHOSPHOPROTEIN; PHOSPHOPROTEIN C JUN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CHOLESTEROL INTAKE; STRESS ACTIVATED PROTEIN KINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME MECHANISM; FLUOROMETRY; GENE EXPRESSION; HYPERCHOLESTEROLEMIA; IMMUNOBLOTTING; IN VIVO STUDY; JNK1 GENE; MALE; MMP 9 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THORACIC AORTA; VITAMIN BLOOD LEVEL; ANIMAL CELL; AORTA; CHOLESTEROL DIET; ENZYME ACTIVITY; IMMUNOPATHOGENESIS; MICROSCOPY; PROTEIN DEGRADATION; PROTEIN FUNCTION; RABBIT MODEL; THERAPY EFFECT; ANIMAL; BLOOD; CHOLESTEROL INTAKE; COMPLICATION; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

ANIMALS; AORTA; ATHEROSCLEROSIS; CHOLESTEROL; CHOLESTEROL, DIETARY; GENE EXPRESSION; HYPERCHOLESTEROLEMIA; MALE; MALONDIALDEHYDE; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASE 8; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; RABBITS; RNA, MESSENGER; SIGNAL TRANSDUCTION; VITAMIN E;

EID: 84904671097     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.02.007     Document Type: Article

References (42)

1. Zhang Y., Wahl L.M. Synergistic enhancement of cytokine-induced human monocyte matrix metalloproteinase-1 by C-reactive protein and oxidized LDL through differential regulation of monocyte chemotactic protein-1 and prostaglandin E2. Journal of Leukocyte Biology 2006, 79:105-113. http://www.ncbi.nlm.nih.gov/pubmed/.
2. Bernhagen J., Krohn R., Lue H., Gregory J.L., Zernecke A., Koenen R.R., et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nature Medicine 2007, 13:587-596. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1038/nm1567.
3. Carmeli E., Harpaz Y., Kogan N.N., Fogelman Y. The effect of an endogenous antioxidant glabridin on oxidized LDL. Journal of Basic and Clinical Physiology and Pharmacology 2008, 19:49-63. http://www.ncbi.nlm.nih.gov/pubmed/.
4. Prasad K. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 1999, 99:1355-1362. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/01.CIR.99.10.1355.
5. Stokes K.Y., Cooper D., Tailor A., Granger D.N. Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radical Biology and Medicine 2002, 33:1026-1036. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0891-5849(02)01015-8.
6. Holvoet P, Vanhaecke J, Janssens S, de Werf F Van, Collen D Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998, 98:1487-1494. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/01.CIR.98.15.1487.
7. Ozer NK, Azzi A Effect of vitamin E on the development of atherosclerosis. Toxicology 2000, 148:179-185. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0300-483X(00)00209-2.
8. Ozer N.K., Sirikci O., Taha S., San T., Moser U., Azzi A. Effect of vitamin E and Probucol on dietary cholesterol-induced atherosclerosis in rabbits. Free Radical Biology and Medicine 1998, 24:226-233. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0891-5849(97)00136-6.
9. Ozer N.K., Negis Y., Aytan N., Villacorta L., Ricciarelli R., Zingg J.M., et al. Vitamin E inhibits CD36 scavenger receptor expression in hypercholesterolemic rabbits. Atherosclerosis 2006, 184:15-20. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.atherosclerosis.2005.03.050.
10. Zhu Y., Lin J.H., Liao H.L., Friedli O, Verna L., Marten N.W., et al. LDL induces transcription factor activator protein-1 in human endothelial cells. Arteriosclerosis, Thrombosis and Vascular Biology 1998, 18:473-480. 10.1161/01.ATV.18.3.473.
11. Rahaman S.O., Lennon D.J., Febbraio M., Podrez E.A., Hazen S.L., Silverstein R.L. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metabolism 2006, 4:211-221. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.cmet.2006.06.007.
12. Chinenov Y., Kerppola T.K. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 2001, 20:2438-2452. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1038/sj.onc.1204385.
13. Droge W. Free radicals in the physiological control of cell function. Physiological Reviews 2002, 82:47-95. http://www.ncbi.nlm.nih.gov/pubmed/.
14. Jung T., Catalgol B., Grune T. The proteasomal system. Molecular Aspects of Medicine 2009, 30:191-296. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.mam.2009.04.001.
15. Sitte N., Huber M., Grune T., Ladhoff A., Doecke W.D., Von Z.T., et al. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 2000, 14:1490-1498.
16. Catalgol B., Ziaja I., Breusing N., Jung T., Hohn A., Alpertunga B., et al. The proteasome is an integral part of solar ultraviolet a radiation-induced gene expression. Journal of Biological Chemistry 2009, 284:30076-30086. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M109.044503.
17. Yassen K.A., Galley H.F., Webster N.R. Matrix metalloproteinase-9 concentrations in critically ill patients. Anaesthesia 2001, 56:729-732. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1046/j.1365-2044.2001.02083.x.
18. Goetzl E.J., Banda M.J., Leppert D. Matrix metalloproteinases in immunity. Journal of Immunology 1996, 156:1-4.
19. Rohde L.E., Ducharme A., Arroyo L.H., Aikawa M., Sukhova G.H., Lopez-Anaya A, et al. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 1999, 99:3063-3070. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/01.CIR.99.23.3063.
20. Nierenberg D.W., Nann S.L. A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples. American Journal of Clinical Nutrition 1992, 56:417-426. http://www.ncbi.nlm.nih.gov/pubmed/.
21. Wong SH, Knight JA, Hopfer SM, Zaharia O, Leach CN, Sunderman FW Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clinical Chemistry 1987, 33:214-220. http://www.ncbi.nlm.nih.gov/pubmed/.
22. Sommerburg O., Grune T., Klee S., Ungemach F.R., Siems W.G. Formation of 4-hydroxynonenal and further aldehydic mediators of inflammation during bromotrichlorornethane treatment of rat liver cells. Mediators of Inflammation 1993, 2:27-31. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1155/S0962935193000031.
23. Catalgol B, Batirel S, Ozer NK Cellular protection and therapeutic potential of tocotrienols. Current Pharmaceutical Design 2011, 17:2215-2220. http://www.ncbi.nlm.nih.gov/pubmed/, 10.2174/138161211796957436.
24. Ogata M., Tsujita M., Hossain M.A., Akita N., Gonzalez F.J., Staels B., et al. On the mechanism for PPAR agonists to enhance ABCA1 gene expression. Atherosclerosis 2009, 205:413-419. http://www.ncbi.nlm.nih.gov/pubmed/.
25. Azzi A., Stocker A. Vitamin E: non-antioxidant roles. Progress in Lipid Research 2000, 39:231-255. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0163-7827(00)00006-0.
26. Ricciarelli R., Zingg J.M., Azzi A. Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation 2000, 102:82-87. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/01.CIR.102.1.82.
27. Pantke U., Volk T., Schmutzler M., Kox W.J., Sitte N., Grune T. Oxidized proteins as a marker of oxidative stress during coronary heart surgery. Free Radical Biology and Medicine 1999, 27:1080-1086. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0891-5849(99)00144-6.
28. Aytan N., Jung T., Tamturk F., Grune T., Kartal-Ozer N Oxidative stress related changes in the brain of hypercholesterolemic rabbits. Biofactors 2008, 33:225-236. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1002/biof.5520330308.
29. Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. Journal of Biological Chemistry 1997, 272:20313-20316. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.272.33.20313.
30. Hershko A., Ciechanover A. The ubiquitin system. Annual Review of Biochemistry 1998, 67:425-479. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1146/annurev.biochem.67.1.425.
31. Harris K.F., Shoji I., Cooper E.M., Kumar S., Oda H., Howley P.M. Ubiquitin-mediated degradation of active Src tyrosine kinase. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:13738-13743. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1073/pnas.96.24.13738.
32. Dong C., Davis R.J., Flavell R.A. MAP kinases in the immune response. Annual Review of Immunology 2002, 20:55-72. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1146/annurev.immunol.20.091301.131133.
33. Wu Y., Luo H., Kanaan N., Wu J. The proteasome controls the expression of a proliferation-associated nuclear antigen Ki-67. Journal of Cellular Biochemistry 2000, 76:596-604. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1002/(SICI)1097-4644(20000315)76:4<596::AID-JCB8>3.3.CO;2-E.
34. Stancovski I., Gonen H., Orian A., Schwartz A.L., Ciechanover A. Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes. Molecular and Cellular Biology 1995, 15:7106-7116. http://www.ncbi.nlm.nih.gov/pubmed/.
35. Jaeschke A., Karasarides M., Ventura J.J., Ehrhardt A., Zhang C., Flavell R.A., et al. JNK2 is a positive regulator of the cJun transcription factor. Molecular Cell 2006, 23:899-911. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.molcel.2006.07.028.
36. Xu Q., Liu Y., Gorospe M., Udelsman R., Holbrook N.J. Acute hypertension activates mitogen-activated protein kinases in arterial wall. Journal of Clinical Investigation 1996, 97:508-514. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1172/JCI118442.
37. 2+ exchanger. Clinical Science 2003, 105:235-242. 10.1042/CS20030033.
38. Touyz R.M., Yao G., Viel E., Amiri F., Schiffrin E.L. Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. Journal of Hypertension 2004, 22:1141-1149. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1097/00004872-200406000-00015.
39. Ricci R., Sumara G., Sumara I., Rozenberg I., Kurrer M., Akhmedov A., et al. Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science 2004, 306:1558-1561. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1126/science.1101909.
40. Galis Z.S., Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circulation Research 2002, 90:251-262. http://www.ncbi.nlm.nih.gov/pubmed/.
41. Moon S.K., Cha B.Y., Kim C.H. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: involvement of the ras dependent pathway. Journal of Cellular Physiology 2004, 198:417-427. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1002/jcp.10435.
42. Tsai C.S., Lin F.Y., Chen Y.H., Yang T.L., Wang H.J., Huang G.S., et al. Cilostazol attenuates MCP-1 and MMP-9 expression in vivo in LPS-administrated balloon-injured rabbit aorta and in vitro in LPS-treated monocytic THP-1 cells. Journal of Cellular Biochemistry 2008, 103:54-66. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1002/jcb.21388.